Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility

Authors: Sanjay Mukherjee, Veena C Vipat, Akhilesh C Mishra, Shailesh D Pawar, Alok K Chakrabarti

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

The world has recently overcome the first influenza pandemic of the 21st century caused by a novel H1N1 virus (pH1N1) which is a triple reassortant comprising genes derived from avian, human, and swine influenza viruses and antigenically quite different from seasonal H1N1 strains. Although the case fatality rates have decreased in many developed countries, the situation is still alarming in many developing countries including India where considerable numbers of new cases are appearing everyday. There is still a high morbidity and mortality of susceptible adult as well as young population without having underlying health issues due to the influenza infection.

Results

To achieve a better understanding of the risk posed by the pH1N1 and to understand its pathogenicity, we studied the host gene expression response to Indian isolate of pH1N1 infection and compared it with seasonal H1N1 infection. The response was studied at four different time points (4, 8, 16 and 24 h) post infection (hpi) in A549 cells using microarray platform. We found that pH1N1 induces immune response earlier than seasonal H1N1 viruses, but at the later stages of infection there is a suppression of host immune responses. The infection with pH1N1 resulted in considerable decrease in the expression of cytokine and other immune genes namely IL8, STAT1, B2 M and IL4 compared to seasonal H1N1.

Conclusion

We propose that the inability to induce strong innate immune response could be a reason for the high transmissibility, pathogenicity and mortality caused by pH1N1 virus.
Appendix
Available only for authorised users
Literature
3.
go back to reference Girard MP, Tam JS, Assossou OM, Kieny MP: The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 2010, 28: 4895-902. 10.1016/j.vaccine.2010.05.031CrossRefPubMed Girard MP, Tam JS, Assossou OM, Kieny MP: The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 2010, 28: 4895-902. 10.1016/j.vaccine.2010.05.031CrossRefPubMed
4.
go back to reference Lu L, Yin Y, Sun Z, Gao L, Gao GF, Liu S, Sun L, Liu W: Genetic correlation between current circulating H1N1 swine and human influenza viruses. J Clin Virol 2010, 49: 186-91. 10.1016/j.jcv.2010.07.018CrossRefPubMed Lu L, Yin Y, Sun Z, Gao L, Gao GF, Liu S, Sun L, Liu W: Genetic correlation between current circulating H1N1 swine and human influenza viruses. J Clin Virol 2010, 49: 186-91. 10.1016/j.jcv.2010.07.018CrossRefPubMed
5.
go back to reference Potdar VA, Chadha MS, Jadhav SM, Mullick J, Cherian SS, Mishra AC: Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One 2010, 5: e9693. 10.1371/journal.pone.0009693PubMedCentralCrossRefPubMed Potdar VA, Chadha MS, Jadhav SM, Mullick J, Cherian SS, Mishra AC: Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One 2010, 5: e9693. 10.1371/journal.pone.0009693PubMedCentralCrossRefPubMed
6.
go back to reference Rowe T, León AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, Ross TM: Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010, 401: 257-65. 10.1016/j.virol.2010.02.020PubMedCentralCrossRefPubMed Rowe T, León AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, Ross TM: Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010, 401: 257-65. 10.1016/j.virol.2010.02.020PubMedCentralCrossRefPubMed
7.
go back to reference Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, et al.: In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460: 1021-1038.PubMedCentralPubMed Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, et al.: In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460: 1021-1038.PubMedCentralPubMed
8.
go back to reference Osterlund P, Pirhonen J, Ikonen N, Rönkkö E, Strengell M, Mäkelä SM, Broman M, Hamming OJ, Hartmann R, Ziegler T, Julkunen I: Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010, 84: 1414-22. 10.1128/JVI.01619-09PubMedCentralCrossRefPubMed Osterlund P, Pirhonen J, Ikonen N, Rönkkö E, Strengell M, Mäkelä SM, Broman M, Hamming OJ, Hartmann R, Ziegler T, Julkunen I: Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010, 84: 1414-22. 10.1128/JVI.01619-09PubMedCentralCrossRefPubMed
9.
go back to reference Baskin CR, Bielefeldt-Ohmann H, Tumpeye TM, Sabourin PJ, Long JP, García-Sastre A, Tolnayd A, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG: Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009, 106: 3455-3460. 10.1073/pnas.0813234106PubMedCentralCrossRefPubMed Baskin CR, Bielefeldt-Ohmann H, Tumpeye TM, Sabourin PJ, Long JP, García-Sastre A, Tolnayd A, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG: Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009, 106: 3455-3460. 10.1073/pnas.0813234106PubMedCentralCrossRefPubMed
10.
go back to reference Cillóniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG: Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 2009, 10: e1000604.CrossRef Cillóniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG: Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 2009, 10: e1000604.CrossRef
11.
go back to reference Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, Banner D, Cheuk Ng D, Socias L, Loza A, Andaluz D, Maravi E, Gómez-Sánchez MJ, Gordón M, Gallegos MC, Fernandez V, Aldunate S, León C, Merino P, Blanco J, Martin-Sanchez F, Rico L, Varillas D, Iglesias V, Marcos MA, Gandía F, Bobillo F, Nogueira B, Rojo S, Resino S, Castro C, Ortiz de Lejarazu R, Kelvin D: Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 2010, 14: R167. 10.1186/cc9259PubMedCentralCrossRefPubMed Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, Banner D, Cheuk Ng D, Socias L, Loza A, Andaluz D, Maravi E, Gómez-Sánchez MJ, Gordón M, Gallegos MC, Fernandez V, Aldunate S, León C, Merino P, Blanco J, Martin-Sanchez F, Rico L, Varillas D, Iglesias V, Marcos MA, Gandía F, Bobillo F, Nogueira B, Rojo S, Resino S, Castro C, Ortiz de Lejarazu R, Kelvin D: Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 2010, 14: R167. 10.1186/cc9259PubMedCentralCrossRefPubMed
12.
go back to reference Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, Baziaka F, Koutoukas P, Savva A, Kanni T, Georgitsi M, Pistiki A, Tsaganos T, Pelekanos N, Athanassia S, Galani L, Giannitsioti E, Kavatha D, Kontopidou F, Mouktaroudi M, Poulakou G, Sakka V, Panagopoulos P, Papadopoulos A, Kanellakopoulou K, Giamarellou H: Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009, 4: e8393. 10.1371/journal.pone.0008393PubMedCentralCrossRefPubMed Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, Baziaka F, Koutoukas P, Savva A, Kanni T, Georgitsi M, Pistiki A, Tsaganos T, Pelekanos N, Athanassia S, Galani L, Giannitsioti E, Kavatha D, Kontopidou F, Mouktaroudi M, Poulakou G, Sakka V, Panagopoulos P, Papadopoulos A, Kanellakopoulou K, Giamarellou H: Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009, 4: e8393. 10.1371/journal.pone.0008393PubMedCentralCrossRefPubMed
13.
go back to reference Lee SMY, Gardy JL, Cheung CY, Cheung TKW, Hui KPY, Ip NY, Guan Y, Hancock REW, Peiris JSM: Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages. PLoS One 2009, 4: e8072. 10.1371/journal.pone.0008072PubMedCentralCrossRefPubMed Lee SMY, Gardy JL, Cheung CY, Cheung TKW, Hui KPY, Ip NY, Guan Y, Hancock REW, Peiris JSM: Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages. PLoS One 2009, 4: e8072. 10.1371/journal.pone.0008072PubMedCentralCrossRefPubMed
14.
go back to reference Mansfield KG: Viral Tropism and the Pathogenesis of Influenza in the Mammalian Host. American Journal of Pathology 2007, 171: 1089-1092. 10.2353/ajpath.2007.070695PubMedCentralCrossRefPubMed Mansfield KG: Viral Tropism and the Pathogenesis of Influenza in the Mammalian Host. American Journal of Pathology 2007, 171: 1089-1092. 10.2353/ajpath.2007.070695PubMedCentralCrossRefPubMed
15.
go back to reference Chakrabarti AK, Vipat VC, Mukherjee S, Singh R, Pawar SD, Mishra AC: Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: A comparative analysis between highly pathogenic and modified viruses. Virol J 2010, 7: 219. 10.1186/1743-422X-7-219PubMedCentralCrossRefPubMed Chakrabarti AK, Vipat VC, Mukherjee S, Singh R, Pawar SD, Mishra AC: Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: A comparative analysis between highly pathogenic and modified viruses. Virol J 2010, 7: 219. 10.1186/1743-422X-7-219PubMedCentralCrossRefPubMed
16.
go back to reference Koyama S, Ishii KJ, Coban C, Akira S: Innate immune response to viral infection. Cytokine 2008, 43: 336-341. 10.1016/j.cyto.2008.07.009CrossRefPubMed Koyama S, Ishii KJ, Coban C, Akira S: Innate immune response to viral infection. Cytokine 2008, 43: 336-341. 10.1016/j.cyto.2008.07.009CrossRefPubMed
17.
go back to reference Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB: Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 2010, 5: e13099. 10.1371/journal.pone.0013099PubMedCentralCrossRefPubMed Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB: Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 2010, 5: e13099. 10.1371/journal.pone.0013099PubMedCentralCrossRefPubMed
18.
go back to reference Le Goffic RL, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B: Influenza A Virus Protein PB1-F2 exacerbates IFN-b Expression of Human Respiratory Epithelial Cells. J Immunol 2010, 185: 4812-4823. 10.4049/jimmunol.0903952CrossRefPubMed Le Goffic RL, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B: Influenza A Virus Protein PB1-F2 exacerbates IFN-b Expression of Human Respiratory Epithelial Cells. J Immunol 2010, 185: 4812-4823. 10.4049/jimmunol.0903952CrossRefPubMed
19.
go back to reference Kuo RL, Zhao C, Malur M, Krug RM: Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. J Virol 2010, 408: 146-158. 10.1016/j.virol.2010.09.012CrossRef Kuo RL, Zhao C, Malur M, Krug RM: Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. J Virol 2010, 408: 146-158. 10.1016/j.virol.2010.09.012CrossRef
20.
go back to reference Mishra AC, Chadha MS, Choudhary ML, Potdar VA: Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India. PLoS One 2010, 5: e10540. 10.1371/journal.pone.0010540PubMedCentralCrossRefPubMed Mishra AC, Chadha MS, Choudhary ML, Potdar VA: Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India. PLoS One 2010, 5: e10540. 10.1371/journal.pone.0010540PubMedCentralCrossRefPubMed
Metadata
Title
Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility
Authors
Sanjay Mukherjee
Veena C Vipat
Akhilesh C Mishra
Shailesh D Pawar
Alok K Chakrabarti
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-140

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine